INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Vascular Solutions, Inc. And Encourages Sha...
December 16 2016 - 11:11PM
Business Wire
The securities litigation law firm of Brower Piven, A
Professional Corporation, has commenced an investigation into
possible breaches of fiduciary duty and other violations of state
law by the Board of Directors of Vascular Solutions, Inc. (Nasdaq:
VASC) (“Vascular Solutions” or the “Company”) relating to the
proposed buyout of Vascular Solutions by Teleflex Incorporated.
Under the terms of the agreement, Vascular Solutions
shareholders are anticipated to receive $56.00 in cash for each
share of Vascular Solutions common stock held. The firm’s
investigation seeks to determine, among other things, whether the
Company’s Board of Directors failed to satisfy their duties to
shareholders, including whether the Board adequately pursued
alternatives to the acquisition and whether the Board obtained the
best price possible for the Company’s shares of common stock.
If you currently own common stock of Vascular Solutions and
believe that the proposed buyout price is too low, and you would
like to learn more about the investigation being conducted by
Brower Piven, please visit our website at
http://www.browerpiven.com/currentinvestigations.html. You may also
request more information by contacting Brower Piven either by email
at hoffman@browerpiven.com or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in
litigating securities and other class action cases and have been
advocating for the rights of shareholders since the 1980s.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161216005698/en/
Brower Piven, A Professional CorporationCharles J. Piven,
410-415-66161925 Old Valley RoadStevenson, Maryland
21153hoffman@browerpiven.com
Vascular Solutions, Inc. (NASDAQ:VASC)
Historical Stock Chart
From Oct 2024 to Nov 2024
Vascular Solutions, Inc. (NASDAQ:VASC)
Historical Stock Chart
From Nov 2023 to Nov 2024